These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8465686)

  • 1. [Clinical assessments on pre-treatment prognostic factors in 138 patients with advanced prostatic carcinoma (stage D2)].
    Kato M; Okada K; Yamashina M; Tohma T; Ishiwata D; Higashi Y; Ohwada F
    Hinyokika Kiyo; 1993 Feb; 39(2):131-4. PubMed ID: 8465686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):275-84. PubMed ID: 2191569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multivariate analysis of prognostic factors in patients with prostatic cancer].
    Miyamoto T; Yuasa M; Furukawa A; Tamura M; Kawanishi Y; Numata A; Imagawa A; Kagawa S
    Hinyokika Kiyo; 1991 Dec; 37(12):1663-8. PubMed ID: 1785390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2.
    Jørgensen T; Kanagasingam Y; Kaalhus O; Tveter KJ; Bryne M; Skjørten F; Berner A; Danielsen HE
    J Urol; 1997 Jul; 158(1):164-70. PubMed ID: 9186346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in stage D2 prostate cancer: results of univariate and multivariate analyses].
    Masukagami T; Akimoto S; Akakura K; Shimazaki J; Murakami S
    Hinyokika Kiyo; 1996 Apr; 42(4):269-74. PubMed ID: 8693958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
    Nakashima J; Tachibana M; Horiguchi Y; Oya M; Ohigashi T; Asakura H; Murai M
    Clin Cancer Res; 2000 Jul; 6(7):2702-6. PubMed ID: 10914713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
    Saito T; Hara N; Kitamura Y; Komatsubara S
    Urology; 2007 Oct; 70(4):702-5. PubMed ID: 17991541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis].
    Kumamoto Y; Tsukamoto T; Umehara T; Harada M; Shimazaki J; Fuse H; Oshima H; Takeuchi H; Yoshida O; Okada K
    Hinyokika Kiyo; 1990 Mar; 36(3):295-305. PubMed ID: 2191571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.
    Nishio S; Katsumata N; Matsumoto K; Tanabe H; Yonemori K; Kohno T; Shimizu C; Ando M; Kasamatsu T; Fujiwara Y
    Oncol Rep; 2008 Feb; 19(2):497-503. PubMed ID: 18202800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma.
    Heng DM; Wee J; Fong KW; Lian LG; Sethi VK; Chua ET; Yang TL; Khoo Tan HS; Lee KS; Lee KM; Tan T; Chua EJ
    Cancer; 1999 Nov; 86(10):1912-20. PubMed ID: 10570413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer.
    Asoglu O; Muslumanoglu M; Igci A; Ozmen V; Karanlik H; Ayalp K; Bozfakioglu Y; Kecer M; Parlak M
    Acta Chir Belg; 2005 Feb; 105(1):62-8. PubMed ID: 15790205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with advanced stage prostate cancer.
    Emrich LJ; Priore RL; Murphy GP; Brady MF
    Cancer Res; 1985 Oct; 45(10):5173-9. PubMed ID: 4027993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
    Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
    Moul JW; Connelly RR; Perahia B; McLeod DG
    J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.